Mangalore Refinery | Business Upturn

Mangalore Refinery Q3 Results: Revenue jumps 16.1% YoY to Rs 29,720 crore, net profit up nearly 4x YoY

Aman Shukla — Wed, 14 Jan 2026 09:59:59 +0000

Mangalore Refinery and Petrochemicals Limited (MRPL) announced its consolidated financial results for the quarter and nine months ended December 31, 2025, reflecting a sharp year-on-year improvement in profitability supported by stronger operating performance and disciplined cost control.

Revenue Performance (YoY)

For Q3 FY26, MRPL reported revenue from operations of ₹29,720 crore, compared with ₹25,601 crore in Q3 FY25, marking a YoY growth of ~16.1%. Total income for the quarter stood at ₹29,759 crore, up from ₹25,634 crore in the same period last year, translating into a YoY increase of ~16.1%.

Expense and Margin Trend (YoY)

Total expenses for Q3 FY26 were reported at ₹27,545 crore, compared with ₹25,165 crore in Q3 FY25, reflecting a YoY rise of ~9.4%. The slower growth in expenses relative to revenue indicates improved operating leverage.

As a result, profit before tax (PBT) rose sharply to ₹2,220 crore in Q3 FY26 from ₹474 crore in Q3 FY25, registering a YoY surge of ~368%.

Net Profit Growth (YoY)

MRPL’s net profit for Q3 FY26 stood at ₹1,451 crore, significantly higher than ₹309 crore reported in Q3 FY25. This translates into a strong YoY growth of ~369% in net profit.

Mangalore Refinery secures US patent for Iso-Butyl Benzene production technology

Aman Shukla — Fri, 30 May 2025 11:27:55 +0000

Mangalore Refinery and Petrochemicals Limited (MRPL) has been awarded a United States patent for its method of preparing iso-Butyl Benzene (i-BB), a key intermediate used in pharmaceutical manufacturing. The patented process, developed in-house, had previously received recognition through an Indian patent.

The patented method centers on a side-chain alkylation process that converts a low-value captive stream into iso-Butyl Benzene using a specially engineered catalyst. This catalyst, developed at MRPL’s Innovation Centre, is designed to achieve high conversion efficiency and selectivity toward the i-BB product.

Iso-Butyl Benzene is an essential raw material in the synthesis of Brufen (ibuprofen), a commonly used non-steroidal anti-inflammatory drug (NSAID). By developing this production process domestically, MRPL aims to reduce dependence on imported intermediates and enhance self-reliance in pharmaceutical ingredient supply.

As part of its scale-up efforts, MRPL is currently establishing a pilot plant for i-BB production. This facility will support the transition from laboratory development to commercial-scale manufacturing.

The patent and ongoing pilot-scale activities reflect MRPL’s focus on advancing technologies relevant to the pharmaceutical and chemical sectors, supporting India’s broader goals in local manufacturing and process innovation.

Q4 results today: IDFC First Bank, India Cements, Mangalore Refinery, Vakrangee and others to announce earnings

Aman Shukla — Sat, 26 Apr 2025 03:20:37 +0000

The fourth quarter earnings season for FY25 continues to gain momentum as several Indian companies are scheduled to release their financial results on April 26, 2025. Investors, analysts, and market participants will be closely monitoring the numbers to gauge the financial health and performance trajectory of these firms.

Below is the list of companies expected to report their Q4FY25 results today:

Companies Releasing Q4FY25 Results – April 26, 2025

ASALCBR (Associated Alcohols & Breweries Ltd)
AVANTEL (Avantel Ltd)
BEPL (Bhansali Engineering Polymers Ltd)
IDFCFIRSTB (IDFC First Bank Ltd)
INDIACEM (The India Cements Ltd)
MANORAMA (Manorama Industries Ltd)
MRPL (Mangalore Refinery and Petrochemicals Ltd)
SBFC (SBFC Finance Ltd)
UGROCAP (UGRO Capital Ltd)
VAKRANGEE (Vakrangee Ltd)

Disclaimer: The above views are based on publicly available information and announcements. They do not constitute investment advice. Please make any and every investment decision after consulting your financial advisor.

Mangalore Refinery launches Toluene production facility to strengthen India’s petrochemical sector

Aman Shukla — Sat, 11 Jan 2025 13:18:53 +0000

Mangalore Refinery and Petrochemicals Ltd (MRPL) has unveiled its new Toluene production facility, inaugurated by Hardeep Singh Puri, Minister of Petroleum and Natural Gas. With an annual capacity of 40 TMT, the facility underscores India’s commitment to self-reliance and global competitiveness in the petrochemical sector.

Toluene, a crucial aromatic hydrocarbon, is used in pharmaceuticals, chemicals, paints, and defense industries. India’s annual Toluene demand is approximately 650 TMT, but domestic production currently meets only 160 TMT. MRPL’s new facility will help bridge this gap, contributing to a foreign exchange savings of around $3 million annually.

This move significantly reduces India’s reliance on Toluene imports, supporting economic growth and the Atmanirbhar Bharat initiative. With this strategic addition, MRPL enhances India’s industrial capabilities and strengthens its position in the global petrochemical market.

Mangalore Refinery shares jump 3% after signing MoU with ISPRL

Aman Shukla — Wed, 08 Jan 2025 05:32:42 +0000

Shares of Mangalore Refinery and Petrochemicals Limited (MRPL) surged 3% following the company’s signing of a Memorandum of Understanding (MoU) with Indian Strategic Petroleum Reserves Ltd. (ISPRL).

The agreement, signed on Tuesday, allows MRPL to utilize ISPRL’s underground caverns for crude oil storage, bolstering its storage capacity and ensuring supply security. This strategic collaboration will help mitigate risks from global market fluctuations while reducing capital expenditure and enhancing operational flexibility. The MoU was signed at MRPL’s office in Mangaluru by key executives from both companies.

Mangalore Refinery and Petrochemicals Ltd. (MRPL) shares opened at ₹145.00, reaching a high of ₹154.50 and a low of ₹144.61. Over the past year, the stock has seen significant fluctuations, with a 52-week high of ₹289.25 and a low of ₹131.55.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

Mangalore Refinery schedules Board meeting on October 29 to consider raising of Rs 5000 crore through NCD

Chittesh Dalmia — Wed, 21 Oct 2020 10:34:53 +0000

Mangalore Refinery and Petrochemicals Limited announced on Wednesday that it has scheduled its Board Meeting on October 29 to approve Q2 FY2021 results. The subsidiary of Oil and Natural Gas Corporation would also discuss on its plan of raising Rs 5000 crore through the issue of Non-Convertible Debentures (NCD).

The Mangaluru based state entity stated in its BSE regulatory filing. “Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform that the meeting of the Board of Directors of the Company has been scheduled for Thursday, 29th October, 2020 inter-alia to consider Un-Audited Financial Statements for the Second Quarter and half year ended 30th September, 2020.”

“Further pursuant to Regulation 29 read with Regulation 50 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we further inform that an agenda item for raising funds of upto Rs 5,000 Crore (Rupees Five Thousand Crore) through issue of Non-convertible Debentures (NCDs) will be placed before the Board Meeting to be held on Thursday, 29th October, 2020.”